Our data also show that bortezomib treatment increased phosphorylation of mitogen-activated protein kinase p38 and Akt as well as higher levels of phosphorylation of the transcription factor STAT5 in tumor-infiltrating CD8+T cells. This evidence concerns the gene WNK2 and neoplasm.